Antigen Discovery, Inc. Company Profile

09:05 EDT 21st March 2018 | BioPortfolio

Antigen Discovery, Inc. (formerly ImmPORT Therapeutics, Inc.) is a privately held biotech company with innovative technologies that offer unprecedented advantages for the rapid development of vaccines, therapeutics, and diagnostic products. The Company's high throughput proteome microarray chip fabrication and screening platform provides an order of magnitude of improvement over current antigen and biomarker discovery technologies. The Company is also working on applying their platform to the identification of markers for autoimmune disease and cancer.

News Articles [492 Associated News Articles listed on BioPortfolio]

Tumor Markers Immunoassay Market, 2025

Immunoassays have played a role in cancer management since the 1960s with the discovery of tumor markers alpha-fetoprotein (AFP) and carcinoembryonic antigen (CEA). These two Read more...

Too Many Too Soon? No!

The results of a study looking at, in part, the "too many, too soon" complaints of antivaccination activists were completely negative. There was no difference in vaccine antigen exposure between two ...

Global and Chinese Carcinoembryonic Antigen Industry, 2017 Market Research Report [Report Updated: 29122017] Prices from USD $3000

The 'Global and Chinese Carcinoembryonic Antigen Industry, 20122022 Market Research Report' is a professional and indepth study on the current state of the global Carcinoembryonic Antigen industry wit...

Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5 Pipeline Review, H1 2018 [Report Updated: 20022018] Prices from USD $3500

Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5 Pipeline Review, H1 2018SummaryCarcinoembryonic Antigen Related C...

Antigen study provides a new approach to vaccine development for RSV

Medical researchers point to a promising route for designing an effective vaccine for the respiratory syncytial virus... The post

North American Vaccine Gains Patent for GBS Vaccine

The US Patent Office has approved a patent for North American Vaccine's (NAV; Columbia, MD) group B streptococcal (GBS) vaccine, which incorporates a GBS polysaccharide conjugated to a C protein alpha...

Blue Oak and PsychoGenics partner on drug discovery

Blue Oak Pharmaceuticals and PGI Drug Discovery have entered into a partnership to discover and optimize novel treatments for brain disorders and psychiatric conditions. Under the terms of the agreeme...

MKSAP: 25-year-old man positive for hepatitis B surface antigen

Test your medicine knowledge with the MKSAP challenge, in partnership with the American College of Physicians. A 25-year-old man is evaluated in follow-up after recently testing positive for hepatit...

Drugs and Medications [48 Associated Drugs and Medications listed on BioPortfolio]

Caraderma [A Refreshing Discovery, Inc.]

CaraDerma acne treatment

Center-al - acacia longifolia pollen [ALK-Abello, Inc.]

Alum Precipitated Extracts

Aplisol [JHP Pharmaceuticals LLC]

APLISOL (Tuberculin Purified Protein Derivative, Diluted [Stabilized Solution])

Short ragweed [Allermed Laboratories, Inc.]

ALLERGENIC EXTRACT Standardized Short Ragweed

Zyflo [Cornerstone Therapeutics Inc.]


PubMed Articles [1208 Associated PubMed Articles listed on BioPortfolio]

CAR T Cells Infiltrate Brain, Safely Target Tumors.

A single dose of peripherally infused CAR T cells cleared antigen-expressing tumor cells in patients with glioblastoma, a 10-person trial found. However, the cells also triggered an immunosuppressive ...

Driving CARs on the uneven road of antigen heterogeneity in solid tumors.

Uniform and strong expression of CD19, a cell surface antigen, on cells of B-cell lineage is unique to hematologic malignancies. Tumor-associated antigen (TAA) targets in solid tumors exhibit heteroge...

PTPN2 Loss Sensitizes Tumor Cells to Immunotherapy.

Ptpn2 loss increases tumor cell IFNγ signaling to enhance antigen presentation and antitumor immunity.

Environmental levels of avian antigen are relevant to the progression of chronic hypersensitivity pneumonitis during antigen avoidance.

In chronic hypersensitivity pneumonitis (chronic HP), antigen avoidance is critical for disease management; however, complete avoidance is difficult because of unrecognized exposure to antigens. Recen...

First-Ever CAR T-cell Therapy Approved in U.S.

The first chimeric antigen receptor T-cell therapy, tisagenlecleucel, received FDA approval for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia who h...

Clinical Trials [999 Associated Clinical Trials listed on BioPortfolio]

Discovery Elbow Multi-Center Prospective Study

The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.

Safety and Immunogencity of H7N9 Influenza Antigen With 2 Adjuvant Formulations in Healthy Adults in Brazil

The overall aim of this study is to evaluate the safety, immunogenicity and dose sparing effects of H7N9 influenza antigen formulated with 2 different adjuvants .

A Clinical Investigation of the Discovery™ Elbow System

The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of fun...

Safety, False-Positive Reactions and Sensitizing Properties of Leishmania Tropica Skin Test Antigen

The efficacy of LtSTA as a skin test antigen depends upon the sensitivity and specificity of the product. This study has been designed to determine if a 15, 30, or 50µg dose shows non-spe...

Endometriosis Biomarker Discovery Study

This is a prospective, Single time point, discovery study intending to identify biomarkers that can differentiate endometriosis from other underlying reasons for pelvic pain. Patients unde...

Companies [1160 Associated Companies listed on BioPortfolio]

Antigen Discovery Inc.

Antigen Discovery Inc. (formerly ImmPORT Therapeutics Inc.) is a privately held biotech company with innovative technologies that offer unprecedented advantages for the rapid development of safer ...

Antigen Discovery, Inc.

Antigen Discovery, Inc. (formerly ImmPORT Therapeutics, Inc.) is a privately held biotech company with innovative technologies that offer unprecedented advantages for the rapid development of vaccines...

Celldex therapeutics

Celldex is a biotechnology company focused on the discovery, development and commercialization of novel immunotherapeutics including human monoclonal antibodies for the treatment of cancer, infectious...

Selecta Biosciences, Inc.

Selecta Biosciences, Inc. is a biopharmaceutical company developing an entirely new class of targeted vaccines that induces an antigen-specific immune activation or antigen...

Genocea Biosciences, Inc.

Genocea Biosciences is a vaccine discovery and development company targeting major infectious diseases with high unmet medical needs, in which T cell responses help confer protect...

More Information about "Antigen Discovery, Inc." on BioPortfolio

We have published hundreds of Antigen Discovery, Inc. news stories on BioPortfolio along with dozens of Antigen Discovery, Inc. Clinical Trials and PubMed Articles about Antigen Discovery, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Antigen Discovery, Inc. Companies in our database. You can also find out about relevant Antigen Discovery, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Corporate Database Quicklinks

Searches Linking to this Company Record